# Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer

> **NCT00238199** · PHASE2 · COMPLETED · sponsor: **OHSU Knight Cancer Institute** · enrollment: 25 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DIETARY_SUPPLEMENT:** calcitriol
- **DRUG:** docetaxel

## Key facts

- **NCT ID:** NCT00238199
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2006-08
- **Final completion:** 2006-08
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2015-04-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00238199

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00238199, "Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00238199. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*